Author

C. Duff

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cell Biology· 1 Genetics· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:differential expression· 2 Research Focus:cell type annotation· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Assay:imaging· 1 Organism:mouse· 1 Assay:spatial transcriptomics· 1

Frequent Co-Authors

A. Cavedon· 2 shared A. Frassetto· 2 shared D. P. Perocheau· 2 shared J. Baruteau· 2 shared L. Rice· 2 shared L. Touramanidou· 2 shared P. Finn· 2 shared P. Martini· 2 shared

Activity by Year

2023-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersGenetics

A. Cavedon

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

The incidence of movement disorders increases with age and contrasts with subtle and limited neuroimaging abnormalities in argininosuccinic aciduria.

S. Gurung, S. Karamched, D. P. Perocheau, K. Seunarine, T. Balwin, L. Touramanidou, C. Duff, N. Elkhateeb, K. Stepien, R. Sharma, A. Morris, T. Hartley, L. Crowther, S. Grunewald, M. Cleary, , J. Baruteau

This study investigates movement disorders in argininosuccinic aciduria (ASA), finding they increase with age and show specific neuroimaging abnormalities not seen in mouse models.

bioRxiv · Oct 10, 2023 · PreprintGenetics

Ex vivo primary liver sections recapitulate disease phenotype and therapeutic rescue for liver monogenic diseases

D. P. Perocheau, J. Baruteau, S. Gurung, L. Touramanidou, C. Duff, G. Sharma, N. Sebire, P. Finn, A. Cavedon, S. Siddiqui, L. Rice, P. Martini, A. Frassetto

This study uses precision-cut liver sections from mice to model monogenic liver diseases and test gene therapy efficacy.

bioRxiv · Mar 23, 2023 · PreprintCell Biology